Epitalon dosage reference: typical range 5 – 20 mg, Daily (PM), cycle 10–20 days on, 4–6 months off (unique cycling pattern). Titration chart…
Synthetic tetrapeptide that activates telomerase to maintain telomere length. Developed by Russian scientist Vladimir Khavinson; one of the most researched longevity peptides.
Published protocol literature for Epitalon describes a typical range of 5 – 20 mg, dosed daily (pm), over a cycle of 10–20 days on, 4–6 months off (unique cycling pattern).
| Parameter | Reported value |
|---|---|
| Typical dose range | 5 – 20 mg |
| Frequency | Daily (PM) |
| Cycle length | 10–20 days on, 4–6 months off (unique cycling pattern) |
| Route | Subcutaneous injection (most published protocols) |
| Diluent | Bacteriostatic water |
| Commonly stacked with | Thymosin Alpha-1 (immune/telomere), GHK-Cu (DNA repair), NAD+ precursors |
Protocols are usually titrated rather than started at the top of the range. The tiers below reflect how Epitalon dosing is commonly stepped in the published protocol literature.
| Tier | Dose | Frequency | Notes |
|---|---|---|---|
| Beginner | 5 mg | Daily (PM) | Improved sleep, subtle energy |
| Intermediate | 10 mg | Daily | Noticeable vitality improvements |
| Advanced | 10–20 mg | Daily | Full anti-aging protocol |
Concentration in mcg/mL equals vial milligrams multiplied by 1000, divided by the millilitres of bacteriostatic water added. Volume per dose in mL equals the target dose in mcg divided by that concentration. On a U-100 insulin syringe, multiply the volume in mL by 100 to read the units.
| Vial | Bacteriostatic water | Resulting concentration |
|---|---|---|
| 2 mg vial | 1 mL bacteriostatic water | 2,000 mcg/mL |
| 5 mg vial | 2 mL bacteriostatic water | 2,500 mcg/mL |
| 10 mg vial | 2 mL bacteriostatic water | 5,000 mcg/mL |
| State | Conditions | Shelf life |
|---|---|---|
| Lyophilized (Powder) | Refrigerate 2–8°C (36–46°F) or freeze | 12–24 months refrigerated; longer frozen |
| Reconstituted | Refrigerate 2–8°C only; no freezing | 21–30 days typically |
| In Transit | Insulated packaging; ice packs | Minimize time; avoid heat exposure |
| MK-677 (Oral) | Room temp okay; cool/dry preferred | Per manufacturer; typically 12+ months |
Dose ranges on this page summarise published research and practitioner protocol literature for Epitalon. They are a reference, not medical direction. All peptide products referenced are intended solely for research, investigational, or licensed professional use. They are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed medical practitioner before any personal or clinical use.
Published protocol literature for Epitalon generally describes 5 – 20 mg, administered daily (pm). Individual protocols vary and should be set by a licensed practitioner.
Daily (PM). Frequency is driven by half-life, so shorter-acting compounds are dosed more often.
Typical cycle length reported is 10–20 days on, 4–6 months off (unique cycling pattern). Cycling exists to limit receptor desensitisation and to create assessment windows, not as a fixed rule.
2mg → 1ml bacteriostatic water; 5mg → 2ml bacteriostatic water; 10mg → 2ml bacteriostatic water. Concentration in mcg/mL equals vial milligrams times 1000 divided by millilitres of bacteriostatic water.
The majority of published work originates from the St. Petersburg Institute of Bioregulation and Gerontology in Russia, with decades of accumulated data.